8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Dec 18, 2024 · 1y ago · Accession 0001558370-24-016343
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Corvus Pharmaceuticals, Inc.
- Ticker
- CRVS
- CIK
- 1626971
- Form type
- 8-K
- Filing date
- Dec 18, 2024
- Report date
- Dec 18, 2024
- Document
- crvs-20241218x8k.htm
- Size
- 596 KB